PUBLISHER: Grand View Research | PRODUCT CODE: 1405912
PUBLISHER: Grand View Research | PRODUCT CODE: 1405912
The global cochlear implant market is anticipated to reach USD 2.77 billion by 2030, growing at a CAGR of 6.02% during the forecast period, according to a new report by Grand View Research, Inc. Hearing loss is a major concern caused by genetic factors, infections, and medications. Favorable reimbursement policies, minimally invasive procedures, and technological advancements are boosting the adoption of cochlear implants.
The increasing approvals of cochlear implants, owing to technological advancements, is expected to boost the market's growth. For instance, in December 2020, Advanced Bionics LLC, a U.S. subsidiary of Sonova, received FDA approval for Naida CI Marvel and Sky CI Marvel sound processors in the United States. These sound processors allow users to customize their implants with the help of machine learning algorithms, based on the wearers' location whether in noisy places or at homes.
Increasing investment in R&D activities for product innovation enables manufacturers to compete with other players to achieve a greater market stronghold. For instance, Cochlear Ltd. increased its investment to USD 199.5 million in 2021 from USD 25.9 million in 2020 . Kanso 2 sound Processor, Nucleus 7 Sound Processor, and custom sound pro fitting software by Cochlear Ltd. are some of the product launched in 2020.
Moreover, several initiatives are being undertaken by governments and various organizations to support research in the field of cochlear implantation. For instance, in March 2022, the ACI Alliance members shared their research and clinical practice at the AAA conference in 2022. The conference aimed to connect with peers, stay updated with upcoming information, and know about recent developments in the audiological industry. This is expected to boost the market's growth.